Tag: Healthcare Innovation Award
Protected: Appas Saha, Public Health, Healthcare Innovation Award
Protected: Ramesh Saha, Computer Science, Healthcare Innovation Award
Protected: Kanaka Durga Devi Nelluri, Pharmacology, Healthcare Innovation Award
Abhijit Saha, Chemistry, Healthcare Innovation Award
Prof. Dr. Abhijit Saha: Professor at The Neotia University, India
Dr. Abhijit Saha, PhD, is a highly motivated and detail-oriented Research Scholar and Professor with extensive expertise in pharmaceutical chemistry, molecular biology, and drug design. Over the past 15 years, he has focused on synthesizing novel anticancer compounds and applying advanced analytical and biological techniques to evaluate their efficacy. His research integrates synthetic organic chemistry with computational drug design and in vitro/in vivo studies, aiming to develop effective therapeutics for multiple cancer types. Passionate about mentoring, he actively guides students and contributes to multidisciplinary research addressing real-world biomedical challenges.
Online Profile
Dr. Abhijit Saha’s research contributions have garnered a total of 11 citations across his publications, with 9 citations coming from his recent impactful works. His scholarly influence is also reflected in an h-index of 2, demonstrating the recognition of his research within the scientific community and his growing presence in the fields of pharmaceutical chemistry and drug design.
Education
Dr. Saha earned his Ph.D. in Pharmaceutical Chemistry from Biju Patnaik University of Technology, Odisha, completing his doctoral research between 2015 and 2023. His thesis focused on the design, synthesis, and biological evaluation of novel anticancer molecules targeting multiple myeloma and other cancer strains. Prior to his Ph.D., he completed his M.Pharm in Pharmaceutical Chemistry at the same university with a strong academic record, followed by a B.Pharm degree from Berhampur University, Odisha, where he graduated with first-class honors.
Research Focus
His research is centered on the development of new anticancer drug candidates through synthetic organic and medicinal chemistry. He specializes in pharmacophore-based drug design and molecular docking studies targeting cancer-related receptors, and method development and validation of pharmaceutical compounds using RP-HPLC, UV, and IR spectroscopy. He is experienced in the biological evaluation of compounds on various cancer cell lines including Sarcoma-180, Ehrlich Ascites Carcinoma, Multiple Myeloma, NSCLC, and Breast cancer. Additionally, he extracts and screens phytochemicals for their antimicrobial and anticancer properties, contributing to natural product research and drug discovery.
Experience
Dr. Saha currently serves as a Professor at The Neotia University, where he delivers lectures in pharmaceutical chemistry and analysis, guides M.Pharm dissertation projects, and provides consultancy services in HPLC, UV spectroscopy, and drug designing. Prior to this, he was a Professor and Associate Professor at the College of Pharmaceutical Sciences in Berhampur, Odisha, where he taught undergraduate and postgraduate courses in pharmaceutical and organic chemistry while supervising numerous research projects. He began his academic career as an Assistant Professor and Lecturer at the same institution, where he gained extensive experience in teaching and mentoring students.
Research Timeline & Activities
In 2025, Dr. Saha coordinated a comprehensive three-day hands-on workshop focused on HPLC and UV spectrophotometry, aimed at enhancing practical skills among researchers and students. From 2015 to 2023, his Ph.D. research involved the design, synthesis, and biological evaluation of novel anticancer agents, with a particular emphasis on apoptosis enhancement and antiangiogenic activity. He has conducted numerous molecular docking and pharmacophore modeling studies to develop multi-target tyrosine kinase inhibitors and has extracted bioactive compounds from medicinal plants to evaluate their anticancer and antimicrobial potential. Additionally, he has developed and validated analytical methods for drug stability and degradation studies using RP-HPLC and UV techniques, contributing to quality control in pharmaceuticals.
Awards & Honors
Dr. Saha’s academic excellence is reflected in his performance on the Graduate Aptitude Test in Engineering (GATE), where he secured an All India Rank of 2420 in 2006 and an 82.97 percentile in 2008. He was awarded a UGC Minor Research Project focusing on the synthesis and biological evaluation of novel glutamic acid analogs with antitumor and antiangiogenic properties. His contributions also include coordinating workshops and successfully mentoring numerous postgraduate research students, highlighting his commitment to academic leadership and professional development.
Top Noted Publication
Among Dr. Saha’s many publications, one of his most notable works is the article titled “Analogue-Based Design, Synthesis, and Antimicrobial Study of Aryl and Heteroaryl Sulfonamides as Multi-Targeted Antimicrobial Compounds,” published in the Russian Journal of Bioorganic Chemistry in 2025. This research presents innovative synthetic strategies and comprehensive biological evaluation of sulfonamide derivatives as potent antimicrobial agents, underscoring his interdisciplinary expertise in drug discovery and design.
-
A Validated Stability Indicating RP-HPLC Method for Estimation of Avapritinib in Bulk and Tablet Dosage Form
Subrata Sen, Koushik Sarker, Avijit Ghosh, Suvasish Mishra, Abhijit Saha
International Journal of Applied Pharmaceutics, 14(2), 95-101, 2021
Citations: 5 -
Possible Antineoplastic Agents, Part XVI: Synthesis, in vivo Antitumor and in vitro Antiangiogenic Study of Few Glutamic Acid Analogs
S. Sen, K. Sarker, A. Ghosh, S. Mishra, A. Saha, D. Goswami, T. Jha, J.K. Gupta
International Journal of Pharmaceutical Sciences and Research, 10(2), 118-124, 2011
Citations: 4 -
Analogue Based Design, Synthesis, Biological Evaluation, and Molecular Docking of Some Thalidomide Metabolites as Selective Cytotoxic and Antiangiogenic Agents Against Multiple Myeloma
A. Saha, K. Sarker, A. Ghosh, S. Mishra, S. Sen
Russian Journal of Bioorganic Chemistry, 48(1), 115-124, 2022
Citations: 1 -
Identification, Biological Evaluation & Retrometabolic Drug Designing of Active Metabolites of 5-Amino-4-(3,4-Dimethoxy Phenyl Sulfonamido)-5-Oxopentanoic Acid (SM-1) As Antimultiple Myeloma and Antiangiogenic Agents
S.S. Abhijit Saha, Koushik Sarker, Avijit Ghosh, Suvasish Mishra
Annals of the Romanian Society for Cell Biology, 25(5), 458-469, 2021
Citations: 1 -
Bioinformatics Approaches for the Validation of Functional Analysis of 3D Cancer Models
Tripti Sharma, Ipsa Padhy, Abhijit Saha (co-author)
In 3D Bioprinting in Cancer Applications, Academic Press, 2025, pp. 85-110
Strengths for the Healthcare Innovation Award
Innovative Anticancer Drug Design and Synthesis
Dr. Abhijit Saha has demonstrated exceptional expertise in the design and synthesis of novel anticancer molecules by integrating traditional synthetic organic chemistry with modern computational techniques such as molecular docking and pharmacophore modeling. His work targets multiple cancer types by developing multi-targeted inhibitors, which enhances therapeutic efficacy while potentially reducing side effects. This innovative approach contributes significantly to advancing personalized and precision medicine in oncology.
Advanced Analytical Method Development and Validation
He has developed and rigorously validated robust stability-indicating analytical methods, including RP-HPLC and UV spectrophotometry, essential for the accurate quantification of pharmaceutical compounds in bulk drugs and dosage forms. These analytical advancements ensure high standards in drug quality control, stability assessment, and regulatory compliance, thereby supporting the safe and effective delivery of medications to patients.
Interdisciplinary and Translational Research Focus
Dr. Saha’s research uniquely combines synthetic chemistry, computational biology, and experimental pharmacology to bridge the gap between laboratory research and clinical application. His translational focus on anticancer and antimicrobial drug development facilitates the transformation of basic scientific discoveries into viable therapeutic agents, addressing critical healthcare challenges and improving patient outcomes.
Leadership in Capacity Building and Academic Mentorship
Beyond his research contributions, Dr. Saha is committed to fostering scientific talent and innovation through the organization of hands-on workshops on HPLC, UV spectroscopy, and drug design techniques. His active mentorship of graduate and postgraduate students encourages the development of practical skills and innovative thinking, preparing a skilled workforce equipped to tackle future healthcare problems.
Significant Scholarly Impact and Collaborative Innovation
With numerous peer-reviewed publications and consistent citation records, Dr. Saha’s work has been recognized internationally for its scientific rigor and innovation. His collaborative efforts with fellow researchers in medicinal chemistry and bioinformatics have led to multidisciplinary projects that enhance the discovery and development of novel therapeutic agents, reinforcing his role as a leader in healthcare innovation.
Ahmed ElMelhat, Sports Science, Healthcare Innovation Award
Assoc. Prof. Ahmed ElMelhat: Associate Prof of Physical Therapy at Beirut Arab University, Lebanon
Title/Designation: Assoc. Prof.
Name: Ahmed ElMelhat
Current Role/Designation: Associate Prof of Physical Therapy
Organization/Institution Details: Beirut Arab University
Country: Lebanon
Subject Track: Sports Science
Key Areas of Expertise: Rehabilitation
Award Categories: Healthcare Innovation Award
Dr. Ahmed M. ElMelhat is an Egyptian academic and clinician with over 15 years of combined clinical, teaching, and research experience in the field of physical therapy. He currently serves as an Assistant Professor at the Faculty of Health Sciences, Beirut Arab University (BAU), Lebanon, and as an Associate Professor in the Department of Physical Therapy for Musculoskeletal Disorders and Sports Injuries, Faculty of Physical Therapy, Cairo University, Egypt. Dr. ElMelhat is renowned for his expertise in musculoskeletal rehabilitation, orthopedic manual therapy, and evidence-based clinical practice. He is a certified Orthopedic Manual Therapist (UK), an active member of the APTA, and holds international affiliations including the International Headache Society. His work bridges academia, clinical practice, and research to advance physiotherapy education and patient care.
Online Profiles
Dr. Ahmed M. ElMelhat has demonstrated a consistent and growing impact in the field of physical therapy research. As per Google Scholar, his work has accumulated a total of 115 citations, with 105 citations received since 2020. He holds an h-index of 5, indicating that at least five of his publications have each been cited five times, and an i10-index of 4, reflecting four publications with ten or more citations. These metrics underscore the relevance and influence of his research, particularly in musculoskeletal rehabilitation, manual therapy, and evidence-based clinical practices.
Education
Dr. ElMelhat earned his Ph.D. in Physical Therapy for Musculoskeletal Disorders and Surgeries from Cairo University in 2019 with a thesis focusing on cervicothoracic mobilization for shoulder impingement syndrome. He obtained his Master’s degree in Orthopedic Physical Therapy in 2015 from the same institution, where he ranked first in his class. His Bachelor’s degree in Physical Therapy was completed in 2009 at Cairo University with distinction (88.68%, ranked 3rd). Throughout his academic journey, he has demonstrated a strong commitment to advanced clinical skills, research excellence, and continuous education.
Research Focus
Dr. ElMelhat’s research interests lie in evidence-based musculoskeletal rehabilitation, particularly the development of clinical prediction rules, manual therapy approaches, and biomechanical analysis in physical therapy. His recent studies explore proximal control strategies, scapular-focused training, and the impact of thoracic manipulation on shoulder and knee pathologies. His work also investigates rehabilitation outcomes in athletes and post-operative patients using validated clinical metrics. Dr. ElMelhat integrates laboratory-based studies with clinical applications, aiming to enhance rehabilitation outcomes and therapeutic decision-making in physical therapy.
Experience
With a multifaceted career, Dr. ElMelhat has held several academic positions including Lecturer, Teaching Assistant, and Supervisor of postgraduate research. He has taught a wide range of courses, including advanced musculoskeletal physical therapy, prosthetics and orthotics, and sports injury management at Cairo University and BAU. Clinically, he has served as a consultant physiotherapist for Al Ahly Sporting Club, Shalan Hospital, and other medical centers. He is highly experienced in the use of isokinetic testing (Biodex), post-operative rehabilitation, and managing complex cases of chronic pain. He has also trained over 1,000 professionals through workshops and postgraduate clinical training programs across the Middle East.
Research Timeline & Activities
Since 2014, Dr. ElMelhat has consistently published in peer-reviewed journals and contributed to international physical therapy conferences. His M.Sc. (2015) explored quadriceps torque in early knee osteoarthritis, while his Ph.D. (2019) examined cervicothoracic mobilization in shoulder impingement. From 2020 onwards, he supervised multiple M.Sc. and Ph.D. theses and led research on scapular stabilization, hip strengthening, and proprioception retraining. He has served as a speaker at major events, including the 23rd International PT Conference at Cairo University (2024) and International PT Conferences in UAE, Egypt, and Lebanon, contributing to knowledge exchange and professional development across borders.
Awards & Honors
Dr. ElMelhat has received multiple recognitions for his academic and clinical contributions. He was awarded by the President of Cairo University (2019) for outstanding international publications and by the Faculty of Physical Therapy for his active role in the WCPT accreditation process. He also received certificates of appreciation for his participation in community medical convoys, national conferences, and continuous education programs. His dedication to academic excellence and social responsibility has made him a respected figure among students, colleagues, and healthcare institutions.
Top Noted Publications
-
Non-Surgical Approaches to the Management of Lumbar Disc Herniation Associated with Radiculopathy
AM ElMelhat, Deed E. Harrison, Ahmed S. A. Youssef, Moustafa R. Zebdawi, Maya A…
Journal of Clinical Medicine, Vol. 13(4), Article 974, 2024
Citations: 45 -
Effect of Equiosmolar Solutions of Hypertonic Sodium Lactate versus Mannitol in Craniectomy Patients with Moderate Traumatic Brain Injury
MR Ahmad, H Hanna
Medical Journal of Indonesia, Vol. 23(1), pp. 30–35, 2014
Citations: 17 -
Effect of Adding Virtual Reality Training to Traditional Exercise Program on Pain, Mental Status and Psychological Status in Unilateral Traumatic Lower Limb Amputees
RL Abbas, D Cooreman, HA Sultan, ME Nayal, IM Saab, AE Khatib, A ElMelhat…
Games for Health Journal, Vol. 13(4), pp. 245–251, 2024
Citations: 12 -
Comparison Between Prophylactic versus Therapeutic Doses of Low-Molecular-Weight Heparin in Severely Ill COVID-19 Patients in Relation to Disease Progression
A ElMelhat, E Elbourai, H Dewedar, T Elgergawi, M Alkhanbouli…
Dubai Medical Journal, Vol. 3(4), pp. 162–169, 2020
Citations: 11 -
Effect of Adding Thoracic Manipulation for the Management of Patients with Adhesive Capsulitis: A Randomized Clinical Trial
AM El Melhat, RL Abbas, MR Zebdawi, AM Ali Ismail
Physiotherapy Theory and Practice, Vol. 41(1), pp. 65–78, 2025
Citations: 9
Strengths for the Healthcare Innovation Award
-
Evidence-Based Innovation in Musculoskeletal Rehabilitation
Dr. ElMelhat has consistently led research that transforms clinical decision-making through the development of clinical prediction rules, biomechanical analysis, and manual therapy approaches. His work bridges the gap between research and real-world application, particularly in conditions like shoulder impingement and knee osteoarthritis, providing clinicians with evidence-backed tools to improve patient outcomes. -
Integration of Technology in Rehabilitation
Demonstrating a forward-thinking approach, Dr. ElMelhat has contributed to virtual reality integration in post-amputation rehabilitation, showing measurable improvements in pain and psychological status. This reflects his commitment to digital health innovation, enhancing traditional physiotherapy practices with cutting-edge technology. -
Capacity Building and Regional Impact
With over 1,000 professionals trained across Egypt, Lebanon, Saudi Arabia, and Jordan, Dr. ElMelhat has played a pivotal role in regional healthcare education and upskilling. His workshops on spinal manipulation and joint rehabilitation contribute to a more skilled, innovative, and responsive physiotherapy workforce across the Middle East. -
Dual Academic-Clinical Leadership
Holding senior positions at both Beirut Arab University and Cairo University, he merges academic rigor with hands-on clinical expertise. His leadership in postgraduate curriculum development, research supervision, and WCPT accreditation demonstrates his ability to drive systemic innovation in physiotherapy education. -
Recognized Research Excellence and Knowledge Dissemination
With over 115 citations, multiple invited lectures, and active contributions to international conferences, Dr. ElMelhat is a recognized thought leader. His publications in top-ranked journals, including the Journal of Clinical Medicine and Physiotherapy Theory and Practice, validate the global relevance and scientific quality of his innovations in healthcare.
Shyam Prakash, Public Health, Healthcare Innovation Award
Dr. Shyam Prakash: Prof ( Additional) at All India Institute of Medical Science, Ansari Nagar, New Delhi, India
Dr. Shyam Prakash is a senior biomedical researcher and Additional Professor at the Department of Laboratory Medicine, All India Institute of Medical Sciences (AIIMS), New Delhi. With over 30 years of experience in clinical biochemistry and molecular diagnostics, he has established himself as a leading expert in the field of gastrointestinal, hepatic, and metabolic diseases. His translational research focuses on bridging laboratory science with patient care through the development of innovative diagnostic tools, point-of-care technologies, and molecular markers for early disease detection. Throughout his career, he has contributed significantly to public health research, diagnostics, and academic mentorship, mentoring over 22 MD and PhD students and authoring 75+ research papers.
Online Profiles
Citation Metrics
As of 2025, Dr. Shyam Prakash has received a total of 2,726 citations, with 1,021 citations since 2020. His h-index stands at 26, indicating substantial impact and consistent contributions across multiple publications. Additionally, his i10-index is 67, with 28 publications having received 10 or more citations since 2020. These metrics reflect the relevance and reach of his research in clinical biochemistry, molecular diagnostics, and translational medicine.
Education
Dr. Prakash received his foundational training in biochemistry and laboratory medicine, beginning his research career in 1993 as a Research Officer in Biochemistry at the Homoeopathic Drug Research Institute, Lucknow. He soon transitioned into forensic science and molecular diagnostics, working briefly at the Central Forensic Science Laboratory, Kolkata, before joining AIIMS in 1994. Over the years, he has continuously upgraded his scientific expertise through multidisciplinary collaborations and research leadership, particularly in the fields of molecular biology, clinical chemistry, and immunodiagnostics.
Research Focus
Dr. Prakash’s primary research interests span the molecular basis of liver and metabolic disorders, including non-alcoholic fatty liver disease (NAFLD), metabolic syndrome, and hepatitis B and C. He investigates the expression of tRNA-derived small RNAs, mitochondrial dysfunction, cytokine signaling, and nitric oxide pathways in chronic diseases. His lab has developed and validated micro-PCR technologies for rapid viral quantification (HBV, HCV, HIV), along with novel biosensors for anemia and salivary glucose detection. He is also involved in studying the role of micronutrients, vascular markers, and oxidative stress in gastrointestinal diseases and cancers.
Experience
Over the past three decades, Dr. Prakash has held several key positions. He joined AIIMS in 1994 as a Senior Scientist in the Department of Gastroenterology and Human Nutrition, where he served until 2014. He was then appointed Assistant Professor in the newly established Department of Laboratory Medicine, becoming Associate Professor in 2017 and Additional Professor in 2020. His earlier roles include Junior Scientific Officer at CFSL, Kolkata (1994), and Research Officer in Biochemistry at HDRI, Lucknow (1993–1994). This extensive experience has given him a deep understanding of both basic and applied biomedical science.
Research Timeline
Dr. Prakash’s research journey began in the early 1990s with clinical biochemistry and expanded into forensic and nutritional science. From 1994 to 2014, his work focused on gastrointestinal biology, where he contributed to understanding micronutrient deficiencies and inflammatory pathways in liver diseases. Since 2014, his research has evolved to include molecular diagnostics, small RNA profiling, oxidative stress biology, and biosensor technology. He now leads several national and collaborative projects funded by ICMR, DST, BIRAC, and AIIMS-IIT Delhi, focusing on advanced diagnostics for metabolic diseases and liver cancer.
Awards & Honors
Dr. Prakash is the recipient of numerous professional memberships and scientific honors. He is an Honorary Member of the Federation Internationale Law, Medicine, Ethics & Innovation (2024) and a Regular Member of the American Society for Biochemistry and Molecular Biology. He is also affiliated with the American Society of Cell Biology, Society for Free Radical Research, Indian Association of Biomedical Sciences, and the Society of Biological Chemists. His contributions have earned him positions on review panels for ICMR and DST, and he serves as a reviewer for the Indian Journal of Clinical Biochemistry and as a Board of Studies member at Poorvanchal University.
Top Noted Publication
Among his recent impactful publications is “Role of prokineticins and T-reg cells in obesity-associated metabolic oxidative dysregulation in NAFLD” (Scientific Reports, 2025), which provides insights into immune-metabolic interactions in liver disease. Another notable study, published in the IEEE Sensors Journal, presents a saliva-based non-invasive glucometer for diabetes management. He also co-authored a 2024 Sci Rep paper on HIV viral load quantification using micro-PCR, and contributed to landmark studies on anemia, PCOS, and biomarkers in metabolic and gastrointestinal diseases published in JAMA Netw Open, Lancet Regional Health, and MethodsX.
-
Prevalence, Phenotypes, and Comorbidities of Polycystic Ovary Syndrome Among Indian Women
JAMA Network Open, 2024, Vol. 7(10): 1–15
Citations: 14
A major population-based study under the PCOS Study Group (PSGS) exploring epidemiological and hormonal patterns among Indian women, with Dr. Prakash as a core contributor. -
Forced Convection Heat Transfer in Doubly Connected Ducts
International Journal of Heat and Fluid Flow, 1987, Vol. 8(2): 107–110
Citations: 14
An early interdisciplinary engineering study co-authored by Dr. Prakash, contributing to thermal flow theory and heat transfer modeling. -
Prevalence of Sarcopenia and Its Determinants in People with Type 2 Diabetes
Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2023, Vol. 17(12): 102902
Citations: 13
A collaborative clinical investigation identifying key predictors of muscle wasting in diabetic patients in northern India. -
Intravenous Iron Sucrose and Hematological Outcomes in Moderately Anemic Pregnant Women
Indian Journal of Public Health, 2020, Vol. 64(1): 11–16
Citations: 13
This study measured changes in hemoglobin, ferritin, and oxidative stress biomarkers following iron therapy in pregnant women. -
Performance and Emission Characteristics of Diesel Engines Using Biodiesel from Safflower and Milk Scum Oil
International Refereed Journal of Engineering and Science, 2014, Vol. 3(4): 103–112
Citations: 13
A cross-disciplinary energy study evaluating biodiesel alternatives for diesel engines, emphasizing Dr. Prakash’s early interest in environmental and engineering research. -
Takayasu’s Disease with Chest Pain, Fever, and Pleural Effusion
Journal of the Association of Physicians of India, 2005, Vol. 53: 722–724
Citations: 13
A clinical case report on the diagnostic complexity of a rare vascular disease, illustrating Dr. Prakash’s broad medical expertise.
Dr. Shyam Prakash’s strength for the Healthcare Innovation Award:
1. Development of Affordable Point-of-Care Diagnostics
Dr. Prakash has led the innovation of low-cost, rapid diagnostic tools such as micro-PCR platforms for HBV, HCV, and HIV, and non-invasive biosensors for anemia and salivary glucose, making advanced diagnostics more accessible in resource-limited settings.
2. Translational Research in Liver and Metabolic Diseases
His work bridges lab science and clinical care through the discovery of molecular markers in NAFLD, hepatitis, and metabolic syndrome, including studies on small RNAs, oxidative stress, and cytokine pathways that enable early detection and targeted treatment.
3. Interdisciplinary Innovation and Engineering Collaboration
By integrating biomedical science with engineering, Dr. Prakash has co-developed novel sensor technologies and bio-analytical devices in partnership with institutes like IIT Delhi, demonstrating a strong track record in translational tech innovation.
4. Public Health Impact Through Large-Scale Clinical Research
He has contributed to major national studies on PCOS, sarcopenia, and anemia, translating research into real-world healthcare improvements and shaping public health strategies, particularly in women’s health and chronic disease management.
5. Leadership in Research and Mentorship
With over 30 years at AIIMS, Dr. Prakash has mentored 22+ MD/PhD scholars, led ICMR and DST-funded projects, and served on national review panels, establishing a legacy of academic leadership, innovation, and capacity building in Indian healthcare.